|
US4052395A
(en)
*
|
1975-09-11 |
1977-10-04 |
Sankyo Company Limited |
Agricultural fungicidal compositions containing 6-(substituted phenyl)-pyridazinones and said pyridazinones
|
|
US4166452A
(en)
*
|
1976-05-03 |
1979-09-04 |
Generales Constantine D J Jr |
Apparatus for testing human responses to stimuli
|
|
US4256108A
(en)
*
|
1977-04-07 |
1981-03-17 |
Alza Corporation |
Microporous-semipermeable laminated osmotic system
|
|
US4279908A
(en)
*
|
1979-04-19 |
1981-07-21 |
Sankyo Company Limited |
Pyridazine derivatives and their use as agricultural fungicides
|
|
US4265874A
(en)
*
|
1980-04-25 |
1981-05-05 |
Alza Corporation |
Method of delivering drug with aid of effervescent activity generated in environment of use
|
|
US4397854A
(en)
*
|
1981-05-14 |
1983-08-09 |
Warner-Lambert Company |
Substituted 6-phenyl-3(2H)-pyridazinones useful as cardiotonic agents
|
|
US4436736A
(en)
*
|
1982-03-29 |
1984-03-13 |
Union Carbide Corporation |
Methods for controlling pests with substituted phenyl thio(thiono)phosphates and the thio(thiono)phosphates
|
|
US4448783A
(en)
*
|
1982-05-17 |
1984-05-15 |
Burroughs Wellcome Co. |
Substituted pyrazoline, and its use in treatment of gastro-intestinal disturbances
|
|
FR2540113A1
(fr)
*
|
1983-01-27 |
1984-08-03 |
Sanofi Sa |
Acides derives de la pyridazine actifs sur le systeme nerveux central
|
|
US5087240A
(en)
*
|
1983-08-18 |
1992-02-11 |
Drug Delivery Systems Inc. |
Transdermal drug patch with conductive fibers
|
|
US4921475A
(en)
*
|
1983-08-18 |
1990-05-01 |
Drug Delivery Systems Inc. |
Transdermal drug patch with microtubes
|
|
DE3627155A1
(de)
*
|
1986-08-11 |
1988-02-18 |
Schering Ag |
Imidazol-derivate
|
|
US5163899A
(en)
*
|
1987-03-20 |
1992-11-17 |
Drug Delivery Systems Inc. |
Transdermal drug delivery system
|
|
US5312325A
(en)
*
|
1987-05-28 |
1994-05-17 |
Drug Delivery Systems Inc |
Pulsating transdermal drug delivery system
|
|
GB8804164D0
(en)
*
|
1988-02-23 |
1988-03-23 |
Tucker J M |
Bandage for administering physiologically active compound
|
|
US5008110A
(en)
*
|
1988-11-10 |
1991-04-16 |
The Procter & Gamble Company |
Storage-stable transdermal patch
|
|
US5088977A
(en)
*
|
1988-12-21 |
1992-02-18 |
Drug Delivery Systems Inc. |
Electrical transdermal drug applicator with counteractor and method of drug delivery
|
|
US6984487B1
(en)
*
|
1989-08-22 |
2006-01-10 |
Hsc Research Development Corporation |
Cystic fibrosis gene
|
|
US5240846A
(en)
*
|
1989-08-22 |
1993-08-31 |
The Regents Of The University Of Michigan |
Gene therapy vector for cystic fibrosis
|
|
CA2031376A1
(en)
*
|
1989-12-04 |
1991-06-05 |
Bahram Farhadieh |
Single layer transdermal drug administration system
|
|
US5100647A
(en)
*
|
1990-10-02 |
1992-03-31 |
The Trustees Of The University Of Pennsylvania |
Method and formulations for the therapy of cystic fibrosis, Bartter's syndrome and secretory diarrheas, and for diuretic treatment
|
|
US5352456A
(en)
*
|
1991-10-10 |
1994-10-04 |
Cygnus Therapeutic Systems |
Device for administering drug transdermally which provides an initial pulse of drug
|
|
CA2123809A1
(en)
*
|
1991-12-18 |
1993-06-24 |
Debra L. Wilfong |
Multilayered barrier structures
|
|
ATE132381T1
(de)
*
|
1992-01-29 |
1996-01-15 |
Voelkl Franz Ski |
Ballspielschläger, insbesondere tennisschläger
|
|
US5234922A
(en)
*
|
1992-09-28 |
1993-08-10 |
University Of Iowa Research Foundation |
Use of sulfonylureas and other potassium channel regulators to treat secretory diarrhea
|
|
US5355215A
(en)
*
|
1992-09-30 |
1994-10-11 |
Environmental Research Institute Of Michigan |
Method and apparatus for quantitative fluorescence measurements
|
|
US5639661A
(en)
*
|
1994-03-23 |
1997-06-17 |
The University Of Iowa Research Foundation |
Genes and proteins for treating cystic fibrosis
|
|
AU2766195A
(en)
*
|
1994-06-03 |
1996-01-05 |
Brigham And Women's Hospital |
Identification of polycystic kidney disease gene, diagnostics and treatment
|
|
US6331555B1
(en)
*
|
1995-06-01 |
2001-12-18 |
University Of California |
Treatment of platelet derived growth factor related disorders such as cancers
|
|
US5670526A
(en)
*
|
1995-12-21 |
1997-09-23 |
Otsuka Pharmaceutical Co., Ltd. |
1,3,4-oxadiazoles
|
|
GB9605808D0
(en)
*
|
1996-03-20 |
1996-05-22 |
Isis Innovation |
CFTR gene regulator
|
|
DE19621312A1
(de)
*
|
1996-05-28 |
1997-12-04 |
Bayer Ag |
Maskierung der Hintergrundfluoreszenz und Signalverstärkung bei der optischen Analyse biologisch medizinischer Assays
|
|
FR2751969B1
(fr)
*
|
1996-08-01 |
1998-12-04 |
Centre Nat Rech Scient |
Composes activateurs du canal cftr, et compositions pharmaceutiques les contenant
|
|
JP4195728B2
(ja)
*
|
1996-10-16 |
2008-12-10 |
ナポ ファーマシューティカルズ，インコーポレーテッド |
プロアントシアニジンポリマー止瀉組成物の腸溶製剤
|
|
DE19647382A1
(de)
*
|
1996-11-15 |
1998-05-20 |
Hoechst Ag |
Heterocyclen als Inhibitoren der Leukozytenadhäsion und VLA-4-Antagonisten
|
|
DE19647381A1
(de)
*
|
1996-11-15 |
1998-05-20 |
Hoechst Ag |
Neue Heterocyclen als Inhibitoren der Leukozytenadhäsion und VLA-4-Antagonisten
|
|
DE19647380A1
(de)
*
|
1996-11-15 |
1998-05-20 |
Hoechst Ag |
5-Ring-Heterocyclen als Inhibitoren der Leukozytenadhäsion und VLA-4-Antagonisten
|
|
AR011913A1
(es)
*
|
1997-03-06 |
2000-09-13 |
Yamano Masaki |
Derivados de 4,4-difluoro-2,3,4,5-tetrahidro-1h-1-benzoazepina y composiciones farmaceuticas de los mismos.
|
|
AU6967198A
(en)
*
|
1997-04-10 |
1998-10-30 |
Eli Lilly And Company |
Diarylsulfonylureas for use in treating secretory diarrhea
|
|
US6096770A
(en)
*
|
1998-08-03 |
2000-08-01 |
American Home Products Corporation |
Anthranilic acid analogs
|
|
US20030195213A1
(en)
*
|
1998-08-21 |
2003-10-16 |
Bailey Thomas R. |
Compounds, compositions and methods for treating or preventing viral infections and associated diseases
|
|
ES2161594B1
(es)
*
|
1998-12-17 |
2003-04-01 |
Servier Lab |
Nuevos derivados de la hidrazida, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
|
|
US6201116B1
(en)
*
|
1999-03-26 |
2001-03-13 |
The Regents Of The University Of California |
Halide indicators
|
|
US6469154B1
(en)
*
|
1999-05-21 |
2002-10-22 |
The Regents Of The University Of California |
Fluorescent protein indicators
|
|
US6545002B1
(en)
*
|
1999-06-01 |
2003-04-08 |
University Of Virginia Patent Foundation |
Substituted 8-phenylxanthines useful as antagonists of A2B adenosine receptors
|
|
GB9919588D0
(en)
*
|
1999-08-18 |
1999-10-20 |
Hoechst Schering Agrevo Gmbh |
Fungicidal compounds
|
|
US20030149113A1
(en)
*
|
2001-10-12 |
2003-08-07 |
Caplan Michael J. |
Conductance of improperly folded proteins through the secretory pathway and related methods for treating disease
|
|
WO2001052847A1
(en)
*
|
2000-01-19 |
2001-07-26 |
Alteon, Inc. |
Thiazole, imidazole and oxazole compounds and treatments of disorders associated with protein aging
|
|
AU2001271998A1
(en)
*
|
2000-07-13 |
2002-01-30 |
The Johns Hopkins University School Of Medicine |
Detection and treatment of polycystic kidney disease
|
|
GB0017084D0
(en)
*
|
2000-07-13 |
2000-08-30 |
Univ Bristol |
Inhibition of the cystic fibrosis transmembrane conductance regulator chloride channel
|
|
AUPR034000A0
(en)
*
|
2000-09-25 |
2000-10-19 |
Fujisawa Pharmaceutical Co., Ltd. |
Aminoalcohol derivatives
|
|
US6852504B2
(en)
*
|
2001-08-08 |
2005-02-08 |
Molecular Devices Corporation |
Method for measuring cellular transmembrane potential changes
|
|
US7159015B2
(en)
*
|
2001-11-16 |
2007-01-02 |
Sun Microsystems, Inc. |
Method and apparatus for managing configuration information in a distributed computer system
|
|
WO2003062453A2
(en)
*
|
2002-01-23 |
2003-07-31 |
Mayo Foundation For Medical Education And Research |
Polycystic kidney disease nucleic acids and proteins
|
|
US7160729B2
(en)
*
|
2002-02-26 |
2007-01-09 |
Hermann Schillers |
Method for detecting diseases that are associated with defects of cystic fibrosis transmembrane conductance regulator (CFTR) protein
|
|
US20040002526A1
(en)
*
|
2002-04-03 |
2004-01-01 |
Cell Therapeutics, Inc. |
Phospholipase D inhibitors and uses thereof
|
|
WO2003105840A2
(en)
*
|
2002-06-17 |
2003-12-24 |
The Pennsylvania State Research Foundation |
Sphingosine kinase inhibitors
|
|
BR0314943A
(pt)
*
|
2002-09-30 |
2005-08-02 |
Univ California |
Inibidores da proteìna reguladora da condutância transmembrana da fibrose cìstica e usos destes
|
|
US7235573B2
(en)
*
|
2002-09-30 |
2007-06-26 |
The Regents Of The University Of California |
Methods of treating secretory diarrhea using cystic fibrosis transmembrane conductance regulator protein inhibitors
|
|
US20040063695A1
(en)
*
|
2002-09-30 |
2004-04-01 |
Alan Verkman |
Cystic fibrosis transmembrane conductance regulator protein inhibitors and uses thereof
|
|
ITRM20020512A1
(it)
*
|
2002-10-10 |
2004-04-11 |
Tenaris Connections Bv |
Tubo filettato con trattamento superficiale.
|
|
AU2003298661B2
(en)
*
|
2002-11-18 |
2007-05-10 |
Chemocentryx, Inc. |
Aryl sulfonamides
|
|
CN1744899A
(zh)
*
|
2002-12-13 |
2006-03-08 |
史密丝克莱恩比彻姆公司 |
作为ccr5拮抗剂的哌啶衍生物
|
|
MXPA05009708A
(es)
*
|
2003-03-10 |
2006-05-25 |
Callisto Pharmaceuticals Inc |
Metodo para el tratamiento de cancer con composiciones de azaspirina.
|
|
EP1601657A1
(en)
*
|
2003-03-12 |
2005-12-07 |
Vertex Pharmaceuticals Incorporated |
Pyrazole modulators of atp-binding cassette transporters
|
|
EP4101846B1
(en)
*
|
2003-04-11 |
2023-08-02 |
PTC Therapeutics, Inc. |
1,2,4-oxadiazole benzoic acid compounds and their use for nonsense suppression and the treatment of disease
|
|
US7696244B2
(en)
*
|
2003-05-16 |
2010-04-13 |
The Regents Of The University Of California |
Compounds having activity in increasing ion transport by mutant-CFTR and uses thereof
|
|
JP4052230B2
(ja)
*
|
2003-11-12 |
2008-02-27 |
トヨタ自動車株式会社 |
内燃機関のノッキング判定装置
|
|
CN101675928A
(zh)
*
|
2003-11-14 |
2010-03-24 |
沃泰克斯药物股份有限公司 |
可用作atp-结合弹夹转运蛋白调控剂的噻唑和噁唑
|
|
BRPI0509282A
(pt)
*
|
2004-03-30 |
2007-09-18 |
Univ California |
compostos contendo hidrazida inibidores de cftr e seus usos
|
|
JP2005314407A
(ja)
*
|
2004-03-31 |
2005-11-10 |
Nippon Nohyaku Co Ltd |
新規なハロアルキルスルホンアニリド誘導体、除草剤及びその使用方法並びにその中間体
|
|
WO2005120497A2
(en)
*
|
2004-06-04 |
2005-12-22 |
The Regents Of The University Of California |
Compounds having activity in increasing ion transport by mutant-cftr and uses thereof
|
|
CA2881078C
(en)
*
|
2004-06-24 |
2018-10-02 |
Vertex Pharmaceuticals Incorporated |
Modulators of atp-binding cassette transporters
|
|
CN101014578B
(zh)
*
|
2004-09-16 |
2011-01-19 |
安斯泰来制药有限公司 |
三唑衍生物或其盐
|
|
TW200616612A
(en)
*
|
2004-10-08 |
2006-06-01 |
Wyeth Corp |
Method for the teatment of polycystic kidney disease field of invention
|
|
TWI359810B
(en)
*
|
2004-11-04 |
2012-03-11 |
Mitsubishi Tanabe Pharma Corp |
Carboxylic acid derivative containing thiazole rin
|
|
JP2008530179A
(ja)
*
|
2005-02-16 |
2008-08-07 |
ソルベイ・フアーマシユーチカルズ・ベー・ブイ |
カンナビノイドｃｂ２受容体モジュレーターとしての１ｈ−イミダゾール誘導体
|
|
WO2006102483A2
(en)
*
|
2005-03-23 |
2006-09-28 |
The Regents Of The University Of California |
Modulation of aquaporin in modulaton of angiogenesis and cell migration
|
|
MX2007012463A
(es)
*
|
2005-04-08 |
2007-11-07 |
Pfizer Prod Inc |
Heteroarilamidas[3.1.0]biciclicas como inhibidores del transporte de glicina de tipo i.
|
|
US20060257934A1
(en)
*
|
2005-04-19 |
2006-11-16 |
Svetlana Tertyshnikova |
Cell-based assay for the quantitative high throughput screening of gamma-aminobutyric acid-induced halide transport
|
|
WO2007044866A2
(en)
*
|
2005-10-11 |
2007-04-19 |
The Regents Of The University Of California |
Water-soluble, fluorescent compounds for detection of potassium ions
|
|
CA2625974A1
(en)
*
|
2005-10-14 |
2007-04-19 |
Neurosearch A/S |
Imidazole derivatives for the treatment of anxiety and related diseases
|
|
US7858649B2
(en)
*
|
2005-10-14 |
2010-12-28 |
Neurosearch A/S |
Imidazole derivatives and their use for modulating the GABAA receptor complex
|
|
EP2016065B1
(en)
*
|
2005-12-28 |
2012-09-19 |
Vertex Pharmaceuticals Incorporated |
1-(benzo[d][1,3]dioxol-5-yl)-n-(phenyl)cyclopropane-carboxamide derivatives and related compounds as modulators of atp-binding cassette transporters for the treatment of cystic fibrosis
|
|
JP5420395B2
(ja)
*
|
2006-04-07 |
2014-02-19 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
Ａｔｐ結合カセット輸送体の調節剤
|
|
NZ572049A
(en)
*
|
2006-05-01 |
2012-08-31 |
Napo Pharmaceuticals Inc |
Method for treatment of constipation-predominant irritable bowel syndrome
|
|
US8228798B2
(en)
*
|
2006-06-28 |
2012-07-24 |
Cisco Technology, Inc. |
QoS-aware service flow mapping in mobile wireless all IP networks
|
|
US7795249B2
(en)
*
|
2006-12-22 |
2010-09-14 |
Millennium Pharmaceuticals, Inc. |
Certain pyrazoline derivatives with kinase inhibitory activity
|
|
US8552067B2
(en)
*
|
2006-12-22 |
2013-10-08 |
The Regents Of The University Of California |
Macromolecular conjugates of cystic fibrosis transmembrane conductance regulator protein inhibitors and uses therefor
|
|
EP2142498A2
(en)
*
|
2007-04-02 |
2010-01-13 |
Institute for Oneworld Health |
Cftr inhibitor compounds and uses thereof
|
|
EP2288592A2
(en)
*
|
2008-04-04 |
2011-03-02 |
The Regents of the University of California |
Divalent hydrazide compound conjugates for inhibiting cystic fibrosis transmembrane conductance regulator
|
|
US8236838B2
(en)
*
|
2008-04-21 |
2012-08-07 |
Institute For Oneworld Health |
Compounds, compositions and methods comprising isoxazole derivatives
|
|
WO2009131958A2
(en)
*
|
2008-04-21 |
2009-10-29 |
Institute For Oneworld Health |
Compounds, compositions and methods comprising triazine derivatives
|
|
US20090263853A1
(en)
*
|
2008-04-21 |
2009-10-22 |
Institute For Oneworld Health |
High-Throughput Cell-Based CFTR Assay
|
|
WO2009131952A1
(en)
*
|
2008-04-21 |
2009-10-29 |
Institute For Oneworld Health |
Compounds, compositions and methods comprising thiazole derivatives
|
|
EP2278879B1
(en)
*
|
2008-04-21 |
2016-06-15 |
PATH Drug Solutions |
Compounds, compositions and methods comprising oxadiazole derivatives
|
|
US20090270398A1
(en)
*
|
2008-04-21 |
2009-10-29 |
Institute For Oneworld Health |
Compounds, Compositions and Methods Comprising Pyridazine Derivatives
|
|
US20100144733A1
(en)
*
|
2008-04-28 |
2010-06-10 |
Institute For Oneworld Health |
Compounds, compositions and methods comprising heteroaromatic derivatives
|
|
US20100267706A1
(en)
*
|
2009-04-20 |
2010-10-21 |
Institute For Oneworld Health |
Compounds, Compositions and Methods Comprising Pyridazine Derivatives
|
|
US8343976B2
(en)
*
|
2009-04-20 |
2013-01-01 |
Institute For Oneworld Health |
Compounds, compositions and methods comprising pyrazole derivatives
|
|
EP2560643A1
(en)
*
|
2010-04-20 |
2013-02-27 |
Institute for OneWorld Health |
Compounds, compositions and methods comprising 1,3,4-oxadiazole derivatives
|
|
US20110288093A1
(en)
*
|
2010-04-20 |
2011-11-24 |
Institute For Oneworld Health |
Compounds, Compositions, and Methods Comprising Pyridazine Sulfonamide Derivatives
|